Vir Biotechnology Inc (VIR)

EBITDA Growth

173.23%

Quarterly · Period ending:

VIR logo

VIR EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported173.23%
VIR Quarterly EBITDA YoY % (-8.30% → 173.23%)
High-resolution chart · PNG

VIR ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vir Biotechnology Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
173.2307%
3.9002%
53.3424%
20.2889%
15.5174%
-83.5351%
14.1774%
-18.1873%
39.914%
34.5653%
23.0164%
-190.6923%
5.9805%
-111.1018%
-125.4469%
772.8571%
-450.7404%
753.2973%
641.4476%
65.0412%
335.4615%
-139.9652%
-80.188%
-83.7431%
22.6409%
-118.3041%
-127.562%
-36.7568%
-26.2677%
-8.3018%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.